Scabies: A comprehensive review and current perspectives.
Sarcoptes scabiei var. hominis
scabies
treatment
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
05
04
2020
revised:
17
05
2020
accepted:
28
05
2020
pubmed:
3
6
2020
medline:
15
5
2021
entrez:
3
6
2020
Statut:
ppublish
Résumé
Human scabies is a contagious skin infestation caused by the parasitic mite Sarcoptes scabiei var. hominis. It is a common skin disease worldwide that occurs not only in the underprivileged sections of society but also in developed countries. In 2009, World Health Organization (WHO) recognized scabies as "neglected tropical disease (NTD)" or NTD thus emphasizing the need for community awareness and proper treatment strategies. This review attempts to summarize the varied clinical presentation of the disease and describes the advances in diagnosis and management including the ongoing search for novel agents to overcome the problems associated with conventional treatments. The literature research includes peer-reviewed articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) till February 2020 and reference lists of respective articles. Only articles published in English language were included.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13746Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Rezaee E, Goldust M, Alipour H. Treatment of scabies: comparison of lindane 1% vs permethrin 5%. Skinmed. 2015;13:283-286.
Cohen PR. Classic and non-classic (Surrepticius) scabies: diagnostic and treatment considerations. Cureus. 2020;12:e7419.
Thompson MJ, Engelman D, Gholam K, Fuller LC, Steer AC. Systematic review of the diagnosis of scabies in therapeutic trials. Clin Exp Dermatol. 2017;42:481-487.
Puza CJ, Suresh V. Scabies and pruritus: a historical review. JAMA Dermatol. 2018;154:536.
Arlian LG, Morgan MS. A review of Sarcoptes scabiei: past, present and future. Parasit Vectors. 2017;10:297.
Pourhasan A, Goldust M, Rezaee E. Treatment of scabies, permethrin 5% cream vs. crotamiton 10% cream. Ann Parasitol. 2013;59:143-147.
Goldust M, Rezaee E. The efficacy of topical ivermectin versus malation 0.5% lotion for the treatment of scabies. J Dermatol Treat. 2013. https://doi.org/10.3109/09546634.2013.782093.
Ranjkesh MR, Naghili B, Goldust M, Rezaee E. The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies. Ann Parasitol. 2013;59:189-194.
Arlian LG, Runyan RA, Achar S, Estes SA. Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol. 1984;11:210-215.
Golant AK, Levitt JO. Scabies: a review of diagnosis and management based on mite biology. Pediatr Rev. 2012;33:e1-e12.
Wollina U. Scabies hominis: ein Update zur Krätze. Ärztebl Sachsen. 2019;30:29-33.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and 366 injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-1602.
Romani L, Steer A, Whitfeld M, Kaldor JM. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis. 2015;15:960-967.
Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5% versus ivermectin. J Dermatol. 2012;39:545-547.
van der Linder N, van Gool K, Gardner K, et al. A systematic review of scabies transmission models and data to evaluate the cost-effectiveness of scabies interventions. PLoS Negl Dis. 2019;13:e0007182.
Mellanby K. The development of symptoms, parasitic infection and immunity in human scabies. Parasitology. 1944;35:197-206.
McCarthy JS, Kemp DJ, Walton SF, Currie BJ. Scabies: more than just an irritation. Postgrad Med J. 2004;80:382-387.
Cassell JA, Middleton J, Nalabanda A, et al. Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis. 2018;18:894-902.
Walton SF, Oprescu FI. Immunology of scabies and translational outcomes: identifying the missing links. Curr Opin Infect Dis. 2013;26:116-122.
Berger TG, Steinhoff M. Pruritus in elderly patients: eruptions of senescence. Semin Cutan Med Surg. 2011;30:113-117.
Taves S, Ji R-R. Itch control by toll-like receptors. Handb Exp Pharmacol. 2015;226:135-150.
Lavery MJ, Stull C, Kinney MO, Yosipovitch G. Nocturnal pruritus: the battle for a peaceful night's sleep. Int J Mol Sci. 2016;17:425.
Misery L. Pruritus: considerable progress in pathophysiology. Med Sci. 2014;30:1123-1128.
Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785-797.
Ostlere L, Harris D, Rustin M. Scabies associated with a bullous pemphigoid-like eruption. Br J Dermatol. 1993;128:217-219.
Veraldi S, Scarabelli G, Zerboni R, Pelosi A, Gianotti R. Bullous scabies. Acta Derm Venereol. 1996;76:167.
Konishi N, Suzuki K, YoshikiToku N. Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid. Acta Derm Venereol. 2000;80:281-283.
Kokubu H, Takahashi T, Tateishi C, et al. Serological investigation of bullous scabies and review of the published work. J Dermatol. 2019;46:e324-e325.
Kaur S, Thami GP. Bullous scabies in an adult. Clin Exp Dermatol. 2003;28:93-94.
Luo DQ, Huang MX, Liu JH, Tang W, Zhao YK, Sarkar R. Bullous scabies. Am J Trop Med Hyg. 2016;95:689-693.
Cohen PR. Scabies masquerading as bullous pemphigoid: scabies surrepticius. Clin Cosmet Investig Dermatol. 2017;10:317-324.
Sil A, Mondal S, Bhanja DB, Datta M, Mukherjee GS, Chakraborty S. Pruritic genital nodules. Pediatr Neonatol. 2020;61:243-244.
Danielsen DG, Boeck W. Treatment of Leprosy or Greek Elephantiasis. Paris: JB Balliere; 1848.
Seidelman J, Garza RM, Smith CM, Fowler VG Jr. More than a mite contagious: crusted scabies. Am J Med. 2017;130:1042-1044.
Bimbi C, Brzezinski P, Sokolowska-Wojdylo M. Crusted (Norwegian) scabies as a strong marker of adult T-cell leukemia/lymphoma in HTLV-1 infection. Clin Case Rep. 2019;7:474-476.
Falk ES, Thorsby E. HLA antigens in patients with scabies. Br J Dermatol. 1981;104:317-320.
Morsy TA, Romia SA, Al-Ganayni GA, Abu-Zakham AA, Al-Shazly AM, Rezk RA. Histocompatibility (HLA) antigens in Egyptians with two parasitic skin diseases (scabies and leishmaniasis). J Egypt Soc Parasitol. 1990;20:565-572.
Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect. 2005;50:375-381.
Arlian LG, Morgan MS, Estes SA, Walton SF, Kemp DJ, Currie BJ. Circulating IgE antibodies with ordinary and crusted scabies. J Med Entomol. 2004;41:74-77.
Davis JS, McGloughlin S, Tong SY, Walton SF, Currie BJ. A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl Trop Dis. 2013;7:e2387.
Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367:1767-1774.
Hill TA, Cohen B. Scabies in babies. Pediatr Dermatol. 2017;34:690-694.
Mohebbipour A, Saleh P, Goldust M, et al. Comparison of oral ivermectin vs. lindane lotion 1% for the treatment of scabies. Clin Exp Dermatol. 2013;38:719-723.
Karthikeyan K. Scabies in children. Arch Dis Child Educ Pract Ed. 2007;92:9.
Eshagh K, DeKlotz CM, Friedlander SF. Infant with a papular eruption localized to the back. JAMA Pediatr. 2014;168:379-380.
Boralevi F, Diallo A, Miquel J, et al. Clinical phenotype of scabies by age. Pediatrics. 2014;133:e910-e916.
Anderson KA, Strowd LC. Epidemiology, diagnosis, and treatment of scabies in a dermatology office. J Am Board Fam Med. 2017;30:78-84.
Heukelbach J, Mazigo HD, Ugbomoiko US. Impact of scabies in resource-poor communities. Curr Opin Infect Dis. 2013;26:127-132.
Kjerkegaard U, Bygum A. Image gallery: scabies incognito. Br J Dermatol. 2019;180:e5.
Werbel T, Hinds BR, Cohen PR. Scabies presenting as cutaneous nodules or malar erythema: reports of patients with scabies surrepticius masquerading as prurigo nodularis or systemic lupus erythematosus. Dermatol Online J 2018; 15:24(9). pii: 13030/qt5bn8k4vx.
Stiff KM, Cohen PR. Scabies surrepticius: Scabies masquerading as pityriasis rosea. Cureus. 2017;9:e1961.
Walter B, Heukelbach J, Fengler G, Worth C, Hengge U, Feldmeier H. Comparison of dermoscopy, skin scraping, and the adhesive tape test for the diagnosis of scabies in a resource-poor setting. Arch Dermatol. 2011;147:468-473.
Head ES, Macdonald EM, Ewert A, Apisarnthanarax P. Sarcoptes scabiei in histopathologic sections of skin in human scabies. Arch Dermatol. 1990;126:1475-1477.
Leung V, Miller M. Detection of scabies: a systematic review of diagnostic methods. Can J Infect Dis Med Microbiol. 2011;22:143-146.
Katsumata K, Katsumata K. Simple method of detecting Sarcoptes scabiei var hominis mites among bedridden elderly patients suffering from severe scabies infestation using an adhesive-tape. Intern Med. 2006;45:857-859.
Abdel-Latif AA, Elshahed AR, Salama OA, Elsaie ML. Comparing the diagnostic properties of skin scraping, adhesive tape, and dermoscopy in diagnosing scabies. Acta Dermatovenerol Alp Pannonica Adriat. 2018;27:75-78.
Argenziano G, Fabbrocini G, Delfino M. Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol. 1997;133:751-753.
Bauer J, Blum A, Sönnichsen K, Metzler G, Rassner G, Garbe C. Nodular scabies detected by computed dermatoscopy. Dermatology. 2001;203:190-191.
Brunetti B, Vitiello A, Delfino S, Sammarco E. Findings in vivo of Sarcoptes scabiei with incident light microscopy. Eur J Dermatol. 1998;8:266-267.
Micali G, Lacarrubba F, Lo GG. Scraping versus videodermatoscopy for the diagnosis of scabies: a comparative study (letter). Acta DermVenereol. 2000;79:396.
Lacarrubba F, Micali G. Videodermatoscopy and scabies. J Pediatr. 2015;163:1227-1227.
Kaur I, Jakhar D. Transillumination dermoscopy of finger web spaces for scabies. J Am Acad Dermatol. 2020;82:e87-e88.
Yoshizumi J, Harada T. ‘Wake sign’: an important clue for the diagnosis of scabies. Clin Exp Dermatol. 2009;34:711-714.
Dupuy A, Dehen L, Bourrat E, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol. 2007;56:53-62.
Park JH, Kim CW, Kim SS. The diagnostic accuracy of dermoscopy for scabies. Ann Dermatol. 2012;24:194-199.
Lacarrubba F, Verzì AE, Micali G. Detailed analysis of in vivo reflectance confocal microscopy for Sarcoptes scabiei hominis. Am J Med Sci. 2015;350:414.
Turan E, Erdemir AT, Gurel MS, Basaran YK. The detection of Sarcoptes scabiei in human skin by in vivo confocal microscopy. Eur J Dermatol. 2011;21:1004-1005.
Levi A, Mumcuoglu KY, Ingber A, Enk CD. Assessment of Sarcoptes scabiei viability in vivo by reflectance confocal microscopy. Lasers Med Sci. 2011;26:291-292.
Banzhaf CA, Themstrup L, Ring HC, Welzel J, Mogensen M, Jemec GB. In vivo imaging of Sarcoptes scabiei infestation using optical coherence tomography. Case Rep Dermatol. 2013;5:156-162.
Arlian LG, Feldmeier H, Morgan MS. The potential for a blood test for scabies. PLoS Negl Trop Dis. 2015;9:e0004188.
Hahm JE, Kim CW, Kim SS. The efficacy of a nested polymerase chain reaction in detecting the cytochrome c oxidase subunit 1 gene of Sarcoptes scabiei var. hominis for diagnosing scabies. Br J Dermatol. 2018;179:889-895.
Engelman D, Fuller LC, Steer AC. International alliance for the control of scabies delphi panel. Consensus criteria for the diagnosis of scabies: a Delphi study of international experts. PLoS Negl Trop Dis. 2018;12:e0006549.
Paller AS. Scabies in infants and small children. Semin Dermatol. 1993;12:3-8.
Strong M, Johnstone P. Interventions for treating scabies. Cochrane Database Syst Rev. 2007;18(3):CD000320.
Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;2(4):CD012994.
Zargari O, Golchai J, Sobhani A, et al. Comparison of the efficacy of topical 1% lindane vs 5% permethrin in scabies: a randomized, double-blind study. Indian J Dermatol Venereol Leprol. 2006;72:33-36.
Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42:236-240.
Abdel-Raheem TA, Meabed EM, Nasef GA. Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies. J Dermatol Treat. 2016;27:473-479.
Alipour H, Goldust M. The efficacy of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies. Ann Parasitol. 2015;61:79-84.
Goldust M, Rezaee E, Raghiafar R. Topical ivermectin versus crotamiton cream 10% for the treatment of scabies. Int J Dermatol. 2014;53:904-908.
Goldust M, Rezaee E, Raghifar R, Hemayat S. Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies. Skinmed. 2014;12:284-287.
Goldust M, Rezaee E, Raghifar R, Naghavi-Behzad M. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Ann Parasitol. 2013;59:79-84.
Goldust M, Rezaee E, Raghifar R, Naghavi-Behzad M. Comparison of permethrin 2.5% cream vs. Tenutex emulsion for the treatment of scabies. Ann Parasitol. 2013;59:31-35.
Goldust M, Rezaee E, Raghifar R. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Cut Ocul Toxicol. 2014;33:333-336.
Panahi Y, Poursaleh Z, Goldust M. The efficacy of topical and oral ivermectin in the treatment of human scabies. Ann Parasitol. 2015;61:11-16.
Thadanipon K, Anothaisintawee T, Rattanasiri S, Thakkinstian A, Attia J. Efficacy and safety of antiscabietic agents: a systematic review and network meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2019;80:1435-1444.
Dhana A, Yen H, Okhovat JP, Cho E, Keum N, Khumalo NP. Ivermectin versus permethrin in the treatment of scabies: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2018;78:194-198.
Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31:1248-1253.
Meumann E, Currie B, Slavin N, Fitzsimmons D, Scott L, Krause V. Healthy Skin Program: Guidelines for Community Control of Scabies, Skin Sores, Tinea and Crusted Scabies in the Northern Territory. Center for Disease Control: Casuarina; 2015.
Mittal RR, Chanchal J, Jindal R. Treatment of nodular scabies. Indian J Dermatol Venereol Leprol 1998; 64:157-8.
Zawar V, Pawar M. Liquid nitrogen cryotherapy in the treatment of chronic, unresponsive nodular scabies. J Am Acad Dermatol. 2017;77:e43-e44.
Khalil S, Abbas O, Kibbi AG, Kurban M. Scabies in the age of increasing drug resistance. PLoS Negl Trop Dis. 2017;11:e0005920.
Mounsey KE, Walton SF, Innes A, Cash-Deans S, McCarthy JS. In vitro efficacy of moxidectin versus ivermectin against Sarcoptes scabiei. Antimicrob Agents Chemother. 2017;61:e00381-e00317.
Korth-Bradley JM, Parks V, Patat A, Matschke K, Mayer P, Fleckenstein L. Relative bioavailability of liquid and tablet formulations of the antiparasitic moxidectin. Clin Pharmacol Drug Dev. 2012;1:32-37.
Gopinath H, Aishwarya M, Karthikeyan K. Tackling scabies: novel agents for a neglected disease. Int J Dermatol. 2018;57:1293-1298.
Goldust M. Oral ivermectin vs. oral fluralaner for the treatment of scabies. Abstract 6533. In: 2018 American Academy of Dermatology Annual Meeting. San Diego, CA. 2018.
Charles V, Charles SX. The use and efficacy of Azadirachta indica ADR (‘neem’) and Curcumalonga (‘turmeric’) in scabies. A pilot study. Trop Geogr Med. 1992;44:178-181.
Oladimeji FA, Orafidiya OO, Ogunniyi TA, Adewunmi TA. Pediculocidal and scabicidal properties of Lippia multiflora essential oil. J Ethnopharmacol. 2000;72:305-311.
Liu X, Walton S, Mounsey K. Vaccine against scabies: necessity and possibility. Parasitology. 2014;14:725-732.
de Beer G, Miller MA, Tremblay L, Monette J. An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control. Infect Control Hospital Epidemiol. 2006;27:517-518.
Sunderkötter C, Feldmeier H, Fölster-Holst R, et al. S1 guidelines on the diagnosis and treatment of scabies - short version. J Dtsch Dermatol Ges. 2016;14:1155-1167.